Current Environment: Development

Warning

Winter Weather

Snow is in the forecast. Consider switching to a virtual visit to receive care from home. Learn more>>

Dev

Research Support | Overview

 

Acknowledgment of Research Support and Donations

The Zetter Lab is grateful to the individuals, research agencies and sponsors who support our work on cancer. This support is used to pay salaries of our research fellows and research assistants and stipends for the students who work in the laboratory. It is also used to purchase the expensive equipment and supplies necessary to conduct this research.

Potential donors who wish to support the work of the laboratory are encouraged to contact:

Ms. Janet Cady
Director, Children's Hospital Trust
Children's Hospital
300 Longwood Avenue
Boston MA 02115
Telephone (617) 355-5340
Email:Janet Cady
or Dr. Zetter at (617) 919-2320
Email:Bruce Zetter

Charles Nowiszewski Professorship
Dr. Zetter wishes to express his gratitude for the generous donation of the Charles Nowiszewski Chair in Cancer Biology at Harvard Medical School and Children's Hospital and for the selection of Dr. Zetter as first incumbent of this endowed chair.

Individual Donors
We wish to acknowledge our gratitude for the generous support of the following individuals who have made substantial contributions to support the work in our laboratory:

  • Ambassador Terry Dornbush, The Hague, The Netherlands
  • Mrs. Susan Franzheim, Dallas, Texas
  • Mr. and Mrs. Arthur Ourieff, Los Angeles, California
  • Mr. Michael Simons, Boston, Massachusetts

Government Agencies
Research in the Zetter laboratory is currently supported by research grants from the following agencies:

  • The National Cancer Institute, National Institutes of Health
  • The U.S. Army Cancer Research Program
  • Harvard Medical School

We also acknowledge previous support from:

  • The American Cancer Society
  • CaPCURE Foundation for Prostate Cancer
  • The David H. Koch Foundation

Corporate Support
We are particularly grateful to Global Medical Technologies for their support of our work on Diagnostic Markers for Prostate Cancer.